Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.46 |
| ▸ | CA2 | P00918 | 5/20 | 0.46 |
| ▸ | EEF2K | O00418 | 2/20 | 0.37 |
| ▸ | EEF2 | P13639 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | PLK4 | O00444 | 1/20 | 0.37 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | TYK2 | P29597 | 1/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | ITK | Q08881 | 1/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2776751 | 0.98 | CA1 (0.49) | CA1CA2EEF2KEEF2KMT2A | |
| Boric Acid SCHEMBL2790572 | 0.94 | CA1 (0.46) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL385087 | 0.93 | CA1 (0.55) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL28416359 | 0.93 | CA1 (0.55) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL5077157 | 0.93 | CA1 (0.55) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL6434689 | 0.93 | CA1 (0.55) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL5682591 | 0.93 | CA1 (0.55) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL28239043 | 0.93 | CA1 (0.51) | CA1CA2EEF2KEEF2KMT2A | |
| SCHEMBL294424 | 0.93 | CA1 (0.51) | CA1CA2EEF2KEEF2KMT2A | |
| Bromide SCHEMBL1330831 | 0.92 | CA1 (0.57) | CA1CA2EEF2KEEF2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | HENKEL AG & CO KGAA (DE) | 2026-03-26 | — | — | US | claimed |
| US-12454635-B2 | Two component (2K) curable adhesive composition | HENKEL AG & CO. KGAA (DE) | 2025-10-28 | — | — | US | claimed |
| US-12398302-B2 | Two component (2K) curable adhesive composition | HENKEL AG & CO. KGAA (DE) | 2025-08-26 | — | — | US | claimed |
| WO-2025119658-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | HENKEL AG & CO. KGAA (DE) | 2025-06-12 | — | — | WO | claimed |
| EP-4567085-A1 | ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM | Henkel AG & Co. KGaA (DE) | 2025-06-11 | — | — | EP | claimed |
| EP-4495067-A1 | METHOD AND APPARATUS FOR PRODUCING SYNTHESIS GAS CONTAINING CARBON MONOXIDE | Kyushu University, National University Corporation (JP) | 2025-01-22 | — | — | EP | claimed |
| WO-2024260662-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | HENKEL AG & CO. KGAA (DE) | 2024-12-26 | — | — | WO | claimed |
| EP-4481913-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | Henkel AG & Co. KGaA (DE) | 2024-12-25 | — | — | EP | claimed |
| US-20240191108-A1 | TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2024-06-13 | — | — | US | claimed |
| EP-3470493-B1 | COMPOSITIONS COMPRISING LATENT HEAT STORAGE MATERIALS | PHASE CHANGE ENERGY SOLUTIONS INC (US) | 2024-05-15 | — | — | EP | claimed |
| US-20060070919-A1 | Process for separating oxygen-containing compounds contained in a hydrocarbon feed, employing an ionic liquid | INSTITUT FRANCAIS DU PETROLE (FR) | 2006-04-06 | — | — | US | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| US-20050150383-A1 | Facilitated transport membranes for an alkene Hydrocarbon separation | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 2005-07-14 | — | — | US | claimed |
| EP-1552875-A1 | Facilitated transport membranes for an alkene hydrocarbon separation | Korea Institute of Science and Technology (KR) | 2005-07-13 | — | — | EP | claimed |
| EP-1201657-B1 | Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst | CENTRE NAT RECH SCIENT (FR) | 2004-05-06 | — | — | EP | claimed |
| US-20040026666-A1 | Imidazolium salts and their use of these ionic liquids as a solvent | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2004-02-12 | — | — | US | claimed |
| EP-1328518-A1 | IMIDAZOLIUM SALTS AND THE USE OF THESE IONIC LIQUIDS AS A SOLVENT | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2003-07-23 | — | — | EP | claimed |
| WO-2002034722-A1 | IMIDAZOLIUM SALTS AND THEIR USE OF THESE IONIC LIQUIDS AS A SOLVENT | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2002-05-02 | — | — | WO | claimed |
| EP-1201657-A1 | Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2002-05-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260088410-A1 | ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS | EPCAM, CDH1, ITGA4 | CA1 536/4885CA2 1889/4885EEF2K 1650/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.